GlassScriptPhysician profile
Christopher L Binette
NPI 1922275866
$31,805.57
in general payments reported to CMS, 2019-2025
27 companies · $6,189 in 2025
The $6,189 reported for 2025 was more than what 86% of Vascular Surgery providers received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,304 · 2020: $1,880 · 2021: $3,342 · 2022: $6,194 · 2023: $6,274 · 2024: $4,622 · 2025: $6,189.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $13K · Travel and Lodging: $4,205 · Education: $50.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $12,830.47 |
| Travel and Lodging | $4,204.68 |
| Education | $50.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Penumbra, INC. | $9,010.21 | 2021-2025 | Indigo System, Penumbra System, Ruby Coil |
| W. L. Gore & Associates, INC. | $7,118.12 | 2019-2025 | Gore Viabahn Vbx Balloon Expandable Endo, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Endologix LLC | $2,657.80 | 2019-2023 | Alto Abdominal Stent Graft System |
| Boston Scientific Corporation | $2,462.80 | 2019-2025 | General - Vascular Intervention, Enroute Transcarotid Stent, Eluvia |
| Medtronic, INC. | $1,609.64 | 2021-2025 | Endurant Iis, Hawkone, Heli-Fx Endoanchor System |
| Silk Road Medical, INC. | $1,488.22 | 2022-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| Philips North America LLC | $957.13 | 2019-2025 | Labosys |
| Cook Medical LLC | $834.76 | 2022-2025 | Zenith Spiral-Z, Zenith, Peel-Away |
| Bard Peripheral Vascular, INC. | $729.34 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Ge Healthcare | $692.28 | 2020 | |
| Cardiovascular Systems INC. | $659.90 | 2019-2023 | Diamondback Peripheral |
| Surmodics, INC. | $618.62 | 2024-2025 | Pounce Venous Thrombectomy System, Pounce Thrombectomy, Pounce Thrombectomy System |
| Shockwave Medical, INC | $575.46 | 2022-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Kerecis Limited | $502.27 | 2024-2025 | Kerecis Omega3 Marigen, Kerecis Surgiclose, Kerecis Omega3 Surgiclose |
| Medtronic Vascular, INC. | $390.90 | 2019-2020 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $388.18 | 2023-2024 | Diamondback Peripheral, Esprit, Aveir |
| Mozarc Medical US LLC | $284.51 | 2023 | Chameleon, Palindrome |
| Stryker Corporation | $176.73 | 2025 | Limflow System, Ozark Cervical Plate System |
| Contego Medical, INC | $169.18 | 2025 | |
| Bolton Medical INC | $162.50 | 2025 | Treo Abdominal Stent-Graft System |
| Argon Medical Devices, INC. | $124.41 | 2023 | Cleaner |
| Depuy Synthes Sales INC. | $92.09 | 2020-2021 | |
| Angiodynamics, INC. | $31.21 | 2021-2022 | |
| Ethicon US, LLC | $21.84 | 2025 | Ethicon, Vistaseal, Surgiflo Hemostatic Matrix |
| Getinge USA Sales, LLC | $20.61 | 2021 | |
| Cashflow Solutions, LLC | $14.77 | 2023 | Lympha Press Optimal Plus(US) Bt, Pcd-51 731a (US) - White, Pcd-52 737a (US) White |
| Medical Device Business Services, INC. | $12.09 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Binette listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.